Publications:

Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).

The Journal Of Biological Chemistry

Stechschulte, Lance A LA; Ge, Chunxi C; Hinds, Terry D TD; Sanchez, Edwin R ER; Franceschi, Renny T RT; Lecka-Czernik, Beata B

Publication Date: 2016-11-18

Variant appearance in text: AD2: S112A

PubMed Link: 27687725

Variant Present in the following documents:

• Main text

View BVdb publication page

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption.

Ebiomedicine

Stechschulte, L A LA; Czernik, P J PJ; Rotter, Z C ZC; Tausif, F N FN; Corzo, C A CA; Marciano, D P DP; Asteian, A A; Zheng, J J; Bruning, J B JB; Kamenecka, T M TM; Rosen, C J CJ; Griffin, P R PR; Lecka-Czernik, B B

Publication Date: 2016-08

Variant appearance in text: AD2: S112A

PubMed Link: 27422345

Variant Present in the following documents:

• mmc1.pdf

View BVdb publication page

A Molecular Evolutionary Reference for the Human Variome.

Molecular Biology And Evolution

Liu, Li L; Tamura, Koichiro K; Sanderford, Maxwell M; Gray, Vanessa E VE; Kumar, Sudhir S

Publication Date: 2016-01

Variant appearance in text: APOE: S112A

PubMed Link: 26464126

Variant Present in the following documents:

• Main text

View BVdb publication page